Skip to content
Review

Formononetin Nanotherapeutics: Overcoming Biopharmaceutical Limitations and Advancing Therapeutic Translation

Sep 2026 · BioNanoScience · Vol 16 · 0 citations · 85 references

TL;DR

Nanocarrier-mediated delivery has shown improved pharmacokinetics, enhanced in vivo efficacy, and greater potential for synergistic combination therapies, and greater potential for synergistic combination therapies.

View source

Similar papers

Review Open access Sep 2026

Phytosomal Delivery of Natural Bioactives: Advancing Bioavailability, Targeted Drug Delivery, and Clinical Translation

Natural bioactive compounds, especially plant-derived phytoconstituents, have gained significant interest due to their structural diversity, multitarget pharmacological activities, and favourable safety profiles. Their pharmaceutical translation is often hindered by poor aqueous solubility, limited membrane permeabilit...

Mohammed Arfath Mysore Ismail, Akhilesh Dubey, A. Shetty et al. · 0 citations
Review Oct 2026

Next-generation nanocrystals of phytochemicals: overcoming bioavailability challenges and enabling targeted therapeutics.

Phytochemicals have gained remarkable attention because of their broad-spectrum therapeutic activities, including antioxidant, anti-inflammatory, antimicrobial, neuroprotective, and anticancer effects. Despite their pharmacological potential, the clinical translation of many phytochemicals remains limited due to poor a...

G. Pramoda, Rahul Shukla · 0 citations
Review Sep 2026

Preclinical advances on diosgenin-loaded nanomedicines.

Overall, nanocarrier-based strategies offer a promising approach to overcome the limitations of diosgenin, maximizing its pharmacological potential.

Mariana Matias, A. S. Martins, Samuel M. Silvestre · 0 citations
Review Open access Sep 2026

Polydatin Delivery Systems and Nanomedicine: Pharmacology, Preclinical Evidence, and Translation

Background: Polydatin has shown anti-inflammatory, antioxidant, and cytoprotective effects in preclinical studies. Its development is limited by low oral bioavailability, extensive metabolism, and poorly defined tissue exposure. Objectives: This review summarizes the pharmacology and delivery systems of polydatin, dist...

Xiao-Ya Li, Ling-Ling Li, Yong-Fang Yuan et al. · 0 citations
Review Open access Sep 2026

Nanocarrier Systems for Plant-Derived Bioactives: Design, Biosafety, and Translational Challenges

Plant-derived bioactives offer diverse pharmacological activities, but their development is often limited by poor aqueous solubility, instability, rapid metabolism, and low tissue exposure. This review examines delivery platforms used to address these constraints, including liposomes, solid lipid nanoparticles, nanostr...

Saima Jan, Gulam Rabbani, Arif Tasleem Jan et al. · 0 citations
Review Open access Aug 2026

Unlocking the opportunities and challenges of green strategies for bioavailability enhancement of polyphenols

Polyphenols are among the most versatile secondary metabolites of plants, with significant therapeutic potential, including anti-inflammatory, cardioprotective, and antioxidant properties. However, limited bioavailability impedes their clinical application. These improvements have led to the use of synthetic stabilizer...

Arya Ojha, Sweta Acharya, Adarsh Sharma et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.